Search - tctmd.com

Displaying 1 - 20 of 39

Sort: Relevancy | Date

News Conference News THT 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Todd Neale

February 14, 2025

Presentation THT 2025

Comparative Outcomes of Temporary Mechanical Circulatory Support in Acute Myocardial Infarction-Related Cardiogenic Shock

Presenter: Qianlan Xi

February 12, 2025

Presentation THT 2025

Limited Myocardial Necrosis With Intracoronary Supersaturated Oxygen Therapy in Acute Anterior Myocardial Infarction: Initial Experience in Routine Practice

Presenter: Andreas Schafer

February 12, 2025

Presentation THT 2025

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Presenter: Kanika Mody

February 12, 2025

Presentation THT 2025

What Lessons Can We Learn from DanGer in the Management of HF-CS

Presenter: Jacob Abraham

February 11, 2025

Presentation THT 2025

Explain the Importance of Timely Identification of Patients in Heart Failure-Cardiogenic Shock (HF-CS)

Presenter: Navin Kapur

February 11, 2025

Presentation THT 2025

Position 1: It Should be Class IIa

Presenter: Manreet Kanwar

February 11, 2025

Presentation THT 2025

Position 2: It Should be Class I

Presenter: Navin Kapur

February 11, 2025

Presentation THT 2025

Clinical Characteristics and Predictors of Mortality in Cardiogenic Shock: A PREMIER Healthcare Database Analysis

Presenter: Joseph Ibrahim

February 11, 2025

Presentation THT 2025

Trends and Outcomes of Revascularization in Cardiogenic Shock: A Matched Cohort Analysis

Presenter: Joseph Ibrahim

February 11, 2025

Presentation THT 2025

Sex Differences in the Utilization and Outcomes of Advanced MCS Devices in Cardiogenic Shock

Presenter: Emily Rodriguez

February 11, 2025

Presentation THT 2025

Prospective Validation of Machine Learning in Risk Stratification of Patients Treated for Cardiogenic Shock

Presenter: Shuojohn Li

February 11, 2025

Presentation THT 2025

Strategy to Prevent Cardiogenic SHOCK: Randomised Clinical Trial (STOPSHOCK - RCT)

Presenter: Allan Böhm

February 11, 2025

Presentation THT 2025

Intensive Conditioning to Reduce Frailty in Cardiogenic Shock: The InCoR-FCS Study

Presenter: Van-Khue Ton

February 11, 2025

Presentation THT 2025

Cardiogenic Shock in the Post-DanGer Shock Trial Era

Presenter: Shelley Hall

February 11, 2025

Presentation THT 2025

Technologies Targeting Acute Limb Ischemia in Cardiogenic Shock

Presenter: Navin Kapur

February 11, 2025

Presentation THT 2024

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Presenter: James W. Schurr

March 06, 2024

Presentation THT 2024

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

Presenter: Thomas Hanff

March 06, 2024

Presentation THT 2024

DPP3-Based Biotherapy in Cardiogenic Shock

Presenter: Mahir Karakas

March 06, 2024

Presentation THT 2024

Ivabridine in Cardiogenic Shock

Presenter: Maya Guglin

March 06, 2024

Advertisement

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Comparative Outcomes of Temporary Mechanical Circulatory Support in Acute Myocardial Infarction-Related Cardiogenic Shock

Limited Myocardial Necrosis With Intracoronary Supersaturated Oxygen Therapy in Acute Anterior Myocardial Infarction: Initial Experience in Routine Practice

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

What Lessons Can We Learn from DanGer in the Management of HF-CS

Explain the Importance of Timely Identification of Patients in Heart Failure-Cardiogenic Shock (HF-CS)

Position 1: It Should be Class IIa

Position 2: It Should be Class I

Clinical Characteristics and Predictors of Mortality in Cardiogenic Shock: A PREMIER Healthcare Database Analysis

Trends and Outcomes of Revascularization in Cardiogenic Shock: A Matched Cohort Analysis

Sex Differences in the Utilization and Outcomes of Advanced MCS Devices in Cardiogenic Shock

Prospective Validation of Machine Learning in Risk Stratification of Patients Treated for Cardiogenic Shock

Strategy to Prevent Cardiogenic SHOCK: Randomised Clinical Trial (STOPSHOCK - RCT)

Intensive Conditioning to Reduce Frailty in Cardiogenic Shock: The InCoR-FCS Study

Cardiogenic Shock in the Post-DanGer Shock Trial Era

Technologies Targeting Acute Limb Ischemia in Cardiogenic Shock

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

DPP3-Based Biotherapy in Cardiogenic Shock

Ivabridine in Cardiogenic Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content